Genotoxicity of inhalation anesthetics halothane and isoflurane in human lymphocytes studied in vitro using the comet assay

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 439, Issue 2, 1999, Pages 199-206

  Jałoszyński, Paweł ^a   Kujawski, Maciej ^a   Wa̧sowicz, Marcin ^b   Szulc, Roman ^b   Szyfter, Krzysztof ^a  

^a INSTITUTE OF HUMAN GENETICS   (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Comet assay; DNA damage; Genotoxicity; Halothane; Inhalation anesthetic; Isoflurane

Indexed keywords

DIMETHYL SULFOXIDE; HALOTHANE; ISOFLURANE;

ADULT; ARTICLE; BLOOD; CELL DEATH; CHEMICAL STRUCTURE; CULTURE MEDIUM; DNA DEGRADATION; DNA STRAND BREAKAGE; DOSE RESPONSE; GEL ELECTROPHORESIS; GENOTOXICITY; HUMAN; HUMAN CELL; LYMPHOCYTE; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

ADULT; ANESTHETICS, INHALATION; DNA DAMAGE; ELECTROPHORESIS, AGAR GEL; HALOTHANE; HUMANS; ISOFLURANE; LYMPHOCYTES; MALE; MUTAGENS;

EID: 0344528613     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5718(98)00195-8     Document Type: Article

References (37)

1. W.C. Stevens, H.G.G. Kingston, Inhalation anesthesia, in: P.G. Barash et al. (Eds.), Clinical Anesthesia (3/e), Lippincott-Raven Publishers, Philadelphia, 1996, pp. 359-383.
2. R.K. Stoelting, Pharmacology and Physiology in Anaesthetic Practice, J.B. Lippincott, Philadelphia, 1987.
3. G. Farell, D. Prendergast, M. Murray, Halothane hepatitis: detection of a constitutional susceptibility factor, New Engl. J. Med. 313 (1985) 1310-1314.
4. Summary of the National Halothane Study: possible association between halothane anesthesia and postoperative hepatic necrosis. JAMA 197 (1977) 775-788.
5. E.N. Cohen, B.W. Brown, D.L. Bruce et al., Occupational disease among operating room personnel: a national study. Report of an ad hoc committee on the effect of trace anesthetics on the health of operating room personnel, American Society of Anesthesiologists, Anesthesiology 41 (1974) 321-340.
6. R.P. Knill-Jones, D.B. Moir, L.V. Rodrigues et al., Anaesthetic practice and pregnancy: a controlled survey of women anaesthetists in the United Kingdom, Lancet 2 (1972) 1326.
7. B. Husum, H.C. Wulf, Sister chromatid exchanges in lymphocytes in operating room personnel, Acta Anaesth. Scand. 24 (1980) 22-24.
8. B. Husum, H.C. Wulf, E. Niebuhr, Monitoring of sister chromatid exchanges in lymphocytes of nurse-anesthetists, Anesthesiology 62 (1985) 475-479.
9. J.M. Baden, M. Kalley, A. Cheung, K. Mortelmans, Lack of mutagens in urines of operating room personnel, Anesthesiology 53 (1980) 195-198.
10. International Agency for Research on Cancer: IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Genetic and Related Effects: an Updating of Selected IARC Monographs, Vol. 1-42, Suppl. 6. IARC, Lyon, 1987.
11. International Agency for Research on Cancer: IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Overall Evaluations of Carcinogenicity: an Updating of Selected IARC Monographs, Vol. 1-42, Suppl. 7. IARC, Lyon, 1987.
12. H. Greim, G. Bonse, Z. Radwan, D. Reichert, D. Henschler, Mutagenicity in vitro and potential carcinogenity of chlorinated ethylenes as a function of metabolic oxirane formation, Biochem. Pharmacol. 24 (1975) 2013-2017.
13. H. Greim, D. Gimboes, G. Egbert, W. Goggelmann, M. Kraemer, Mutagenicity and chromosomal aberrations as an analytical tool for in vitro detection of mammalian enzyme-mediated formation of reactive metabolites, Arch. Toxicol. 39 (1977) 159-169.
14. M. Cerna, H. Kypenova, Mutagenic activity of chloroethylenes analyzed by screening system test, Mutation Res. 46 (1977) 214-215.
15. M.M. Shabin, R.C. von Borstel, Mutagenic and lethal effects of alpha-benzene hexachloride, dibutyl phthalate and trichloroethylene in Saccharomyces cerevisiae, Mutation Res. 48 (1977) 173-180.
16. R. Fahring, Mammalian spot test (Fellfleckentest) with mice, Arch. Toxicol. 38 (1977) 87-98.
17. R. Fahring, The sensitivity of the mammalian spot test to mutagens of different types of action, Mutation Res. 46 (1977) 202.
18. J.M. Baden, M. Kelley, R.I. Mazze, V.F. Simmon, Mutagenicity of inhalation anaesthetics: trichloroethylene, divinyl ether, nitrous oxide and cyclopropane, Br. J. Anaesth. 51 (1979) 417-420.
19. A.E. White, S. Takehisa, E.I. Eger, S. Wolff, W.C. Stevens, Sister chromatid exchanges induced by inhaled anesthetics, Anesthesiology 50 (1979) 426-430.
20. J.M. Baden, M.J. Kelley, R.S. Wharton, B.A. Hitt, R.I. Mazze, V.F. Simmon, Mutagenicity of fluroxene, Anesthesiology 45 (1976) 695.
21. J.M. Baden, M.J. Kelley, V.F. Simmon, S.A. Rice, R.I. Mazze, Fluroxene mutagenicity, Mutation Res. 58 (1978) 183-191.
22. P.G.N. Kramer, A.G.L. Burm, Mutagenicity studies with halothane in Drosophila melanogaster, Anesthesiology 50 (1979) 510-513.
23. H.N. Edmunds, J.M. Baden, V.F. Simmon, Mutagenicity studies with volatile metabolites of halothane, Anesthesiology 51 (1979) 424-429.
24. A.J. Garro, R.A. Philips, Mutagenicity of the halogenated olefin, 2-bromo-2-chloro-1,1-difluoroethylene, a presumed metabolite of the inhalation anesthetic halothane, Environ. Health Perspect. 21 (1977) 65-69.
25. J.E. Sturrock, J.F. Nunn, Synergism between halothane and nitrous oxide in the production of nuclear abnormalities in the dividing fibroblasts, Anesthesiology 44 (1976) 461-471.
26. W.B. Coate, B.M. Ulland, T.R. Lewis, Chronic exposure to low concentrations of halothane-nitrous oxide: reproductive and cytogenetic effect in the rat, Anesthesiology 50 (1979) 310-318.
27. 2O and several insecticides, Mutation Res. 26 (1974) 445.
28. J.M. Baden, V.F. Simmon, Mutagenic effects of inhalational anesthetics, Mutation Res. 75 (1980) 169-189.
29. N.P. Singh, M.T. McKoy, R. Tice, E.L. Schneider, A simple technique for quantitation of low levels of DNA damage in individual cells, Exp. Cell Res. 175 (1988) 184-191.
30. P. Jałoszyński, M. Kujawski, M. Czub-Świerczek, J. Markowska, K. Szyfter, Bleomycin-induced DNA damage and its removal in lymphocytes of breast cancer patients studied by comet assay, Mutation Res. 385 (1997) 223-233.
31. L.L. Ferstandig, Fluorinated anesthetics, in Chemistry of Organic Fluorine Compounds II. A Critical Review, in: M. Hudlický, A.E. Pavlath (Eds.), ACS Monograph 187, American Chemical Society, Washington, DC, 1995, pp. 1133-1137.
32. L.A. Widger, A.J. Gandolfi, R.A. van Dyke, Hypoxia and halothane metabolism in vivo; release of inorganic fluoride and halothane metabolite binding to cellular constituents, Anesthesiology 44 (1976) 197-201.
33. E.N. Cohen, J.R. Trudell, H.N. Edmunds, E. Watson, Urinary metabolites of halothane in man, Anesthesiology 43 (1975) 392-401.
34. W.B. Coate, B.M. Ulland, T.R. Lewis, Chronic exposure to low concentrations of halothane-nitrous oxide: lack of carcinogenic effect effects in the rat, Anesthesiology 50 (1979) 306-309.
35. C.J. Kusyk, T.C. Hsu, Mitotic anomalies induced by three inhalation halogenated anesthetics, Environ. Res. 12 (1976) 366-370.
36. L. Henderson, A. Wolfreys, J. Fedyk, C. Bourner, S. Windebank, The ability of the comet assay to discriminate between genotoxins and cytotoxins, Mutagenesis 13 (1) (1998) 89-94.
37. T. Katoh, Y. Suguro, R. Nakajima, T. Kazama, K. Ikeda, Blood concentrations of sevoflurane and isoflurane on recov-ery from anaesthesia, Br. J. Anaesth. 69 (3) (1992) 259-262.